HВcorAg expression in HВeАg-negative hepatitis: correlation to clinical and histological activity and HВsAg-status
Abstract
Aim of investigation. Assessment of HВcorAg expression features and interrelations of necrotic - inflammatory process with the level and distribution of HBcorAg in hepatocytes in patients with HBeAgnegative AbHBe-positive chronic hepatitis B (CHB) having different HBsAg-status.
Material and methods. Overall 32 patients HBeAg (–) AbHBe (+) CHB were studied: 13 – with HВsAg and 19 – without HВsAg. HBcorAg was estimated in liver tissue by immunehistochemical method («Novocastra» UK tests-systems). Routine laboratory tests, Knodell histological activity index and modified index, Metavir fibrosis score were assessed.
Results. In 25 patients (78,1%) cytoplasmic and nuclear HBcorAg expression and in 7 (21,9%) – only cytoplasmic HBcorAg expression was revealed. Cytoplasmic HВcorAg level was significantly (9-fold) higher, than that in nucleus. Cytoplasmic HBcorAg distribution was distinct: 20 patients (62,5%) had peripheral juxtamembrane and 12 (37,5%) – diffuse expression. The severity of necrotic and inflammatory syndrome according to laboratory and histological data was higher at cytoplasmatic expression of nuclear protein (NP), than at nucleocytoplasmic, and was also higher at peripheral juxtamembrane NP expression, than at diffuse.
Conclusions. НBcorAg expression did not depend on HВsAg-status, but in HВsAg-negative patients grade of parenchymatous damage, premalignant hepatocyte changes i.e. micro- and macrocellular dysplasia was higher, than in HВsAg-positive patients.
About the Authors
O. P. Dudanova
Petrozavodsk State University
Russian Federation
Russian Federation
I. A. Pravdolyubova
Петрозаводский государственный университет
Russian Federation
Russian Federation
References
1. Bonino F, Piratvisuth T, Brunetto MR, Liaw Y-F. Diagnostic markers of chronic hepatitis B infection and disease. Antiviral Ther. 2010; 15(3):35–44.
2. Дуданова ОП, Яхонтова ОИ, Нагорнев ВА, и др. Значение иммуногистохимического метода исследования в диагностике хронического гепатита В и С. Мед. академ. журн. 2005; 5(4):93–9.
3. Дуданова ОП. Клинико-диагностические особенности и прогноз эффективности терапии различных фенотипических и генотипических форм хронических гепатитов В, С и микст-гепатита В+С: Автореф. дис. д-ра мед. наук. 2006; СПб: 35.
4. Gerner P, Friedt M, Oettinger R, et al. The hepatitis B virus seroconversion to anti-HBe is frequently associated with HBV genotype changes and selection of preS2-defective particles in chronically infected children. Virology. 1998; 245:163–72.
5. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepatol. 2002; 9(4):243–57.
6. Chan H, Tsang S, Leung N. et al. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. Am J Gastroenterol. 2002; 97(5):1211–5.
7. Lledó JL, Fernández C, Gutiérrez ML, Ocaña S. Management of occult hepatitis B virus infection: An update for the clinician. World J Gastroenterol. 2011; 17(12):1563–8.
8. Hadziyannsi SJ, Liebermahn M, Karvountzgis G, Shafritdz A. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg vs. anti-HBe positive carriers of hepatitis B virus. Hepatology. 1983; 3:656–62.
9. Chu Ch-M, Liaw YF. Intrahеpatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Gastroenterology. 1987; 92:220–5.
10. Naumov NV, Portmann BC, Tedder RS, et al. Detection of hepatitis B virus agents in liver tissue. Gastroenterology. 1990; 99:1248–53.
11. Park YN, Han KH, Kim KS, et al. Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: role of precore stop mutants. Liver. 1999; 19:199–205.
12. Li H-C, Huang E-Y, Su P-Y, et al. Nuclear export and import of human hepatitis B virus capsid protein and particles. PloS Pathogens. 2010; 6(10):e1001162.
13. Chen BF, Liu CJ, Jow GM, et al. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology. 2006; 130:1153–68.
14. Anthony PP, Vogel CL, Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol. 1973; 26:217–23.
15. Watanabe S, Okita K, Нarada T, et al. Morphologic studies of the liver cell dysplasia. Cancer. 1983; 51:2197–205.
16. Ikeda H, Sasaki M, Sato Y, et al. Large cell change of hepatocytes in chronic viral hepatitis represents a senescent-related lesion. Hum Pathol. 2009; 40:1774–82.
Review
For citations:
Dudanova O.P., Pravdolyubova I.A. HВcorAg expression in HВeАg-negative hepatitis: correlation to clinical and histological activity and HВsAg-status. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2012;22(2):53-59. (In Russ.)
Views:
58
Email this article 
